Russia approves first Covid-19 prescription drug for sale in pharmacies

0:00
play article
Subscribers can listen to this article
(Getty)
(Getty)

Russia has approved R-Pharm's Coronavir treatment for outpatients with mild to moderate Covid-19 infections and the antiviral drug could be rolled out to pharmacies in the country as soon as next week, the company said on Friday.

Coronavir's approval as a prescription drug follows the green light for another Russian Covid-19 drug, Avifavir, in May. Both are based on favipiravir, which was developed in Japan and is widely used there as the basis for viral treatments.

R-Pharm's announcement is another sign Russia is pushing hard to take a global lead in the race against the virus. It is already exporting its Covid-19 tests and has clinched several international deals for supplies of its Sputnik-V vaccine.

R-Pharm said it received approval for Coronavir after Phase III clinical trials involving 168 patients with Covid-19.

The drug was first approved for in-hospital use to treat Covid-19 in July, a government register showed.

Coronavir's trial was comparatively small. The European health regulator on Friday endorsed the use of the steroid dexamethasone in the treatment of Covid-19 patients after a study by UK researchers on several thousand patients.

R-Pharm has started talks with pharmacies about orders, the company's spokesperson said, with Coronavir supplies expected to be rolled out in the near future, possibly as soon as next week.

Coronavir is made at R-Pharm's facility in Yaroslavl, about 300km northeast of Moscow.

Avifavir has been available in hospitals since June but has yet to be supplied to pharmacies.

Both are based on the active ingredient favipiravir, which is also the key component in Fujifilm Holdings Corp's antiviral drug Avigan, approved in Japan as an emergency influenza treatment in 2014.

Trials to test it against Covid-19 are ongoing around the world. Results of a Japanese study in July were inconclusive.

It is produced by various Indian generic drugmakers including Lupin, Cipla and Dr Reddy's for use against Covid-19 in India.

We live in a world where facts and fiction get blurred
In times of uncertainty you need journalism you can trust. For only R75 per month, you have access to a world of in-depth analyses, investigative journalism, top opinions and a range of features. Journalism strengthens democracy. Invest in the future today.
Subscribe to News24
Lockdown For
DAYS
HRS
MINS
Voting Booth
Who do you think is going to win the 2020 US election?
Please select an option Oops! Something went wrong, please try again later.
Results
Biden is going to take it
46% - 7462 votes
It's four more years for Trump
54% - 8591 votes
Vote
ZAR/USD
16.19
(-0.10)
ZAR/GBP
21.11
(-0.12)
ZAR/EUR
19.19
(-0.12)
ZAR/AUD
11.55
(-0.13)
ZAR/JPY
0.15
(-0.14)
Gold
1901.55
(+0.01)
Silver
24.57
(+0.10)
Platinum
902.03
(+0.40)
Brent Crude
41.85
(-1.66)
Palladium
2378.04
(+0.61)
All Share
55339.58
(+0.99)
Top 40
50692.28
(+0.83)
Financial 15
10790.70
(+3.99)
Industrial 25
74905.70
(+1.05)
Resource 10
52561.57
(-0.49)
All JSE data delayed by at least 15 minutes morningstar logo